Literature DB >> 30877133

Oncogenes calling on a lysosomal Ca2+ channel.

Daniella M Schwartz1, Shmuel Muallem2.   

Abstract

Mesh:

Year:  2019        PMID: 30877133      PMCID: PMC6446195          DOI: 10.15252/embr.201947953

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  10 in total

Review 1.  Lysosomal physiology.

Authors:  Haoxing Xu; Dejian Ren
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

Review 2.  From mucolipidosis type IV to Ebola: TRPML and two-pore channels at the crossroads of endo-lysosomal trafficking and disease.

Authors:  Christian Grimm; Elisabeth Butz; Cheng-Chang Chen; Christian Wahl-Schott; Martin Biel
Journal:  Cell Calcium       Date:  2017-04-23       Impact factor: 6.817

Review 3.  The complex relationship between TFEB transcription factor phosphorylation and subcellular localization.

Authors:  Rosa Puertollano; Shawn M Ferguson; James Brugarolas; Andrea Ballabio
Journal:  EMBO J       Date:  2018-05-15       Impact factor: 11.598

4.  Genetic Analysis Reveals AMPK Is Required to Support Tumor Growth in Murine Kras-Dependent Lung Cancer Models.

Authors:  Lillian J Eichner; Sonja N Brun; Sébastien Herzig; Nathan P Young; Stephanie D Curtis; David B Shackelford; Maxim N Shokhirev; Mathias Leblanc; Liliana I Vera; Amanda Hutchins; Debbie S Ross; Reuben J Shaw; Robert U Svensson
Journal:  Cell Metab       Date:  2018-11-08       Impact factor: 27.287

Review 5.  Ras and the Plasma Membrane: A Complicated Relationship.

Authors:  Yong Zhou; Priyanka Prakash; Alemayehu A Gorfe; John F Hancock
Journal:  Cold Spring Harb Perspect Med       Date:  2018-10-01       Impact factor: 6.915

Review 6.  TRPML1: The Ca(2+)retaker of the lysosome.

Authors:  Simone Di Paola; Anna Scotto-Rosato; Diego Luis Medina
Journal:  Cell Calcium       Date:  2017-06-24       Impact factor: 6.817

7.  HRAS-driven cancer cells are vulnerable to TRPML1 inhibition.

Authors:  Jewon Jung; Kwang-Jin Cho; Ali K Naji; Kristen N Clemons; Ching On Wong; Mariana Villanueva; Steven Gregory; Nicholas E Karagas; Lingxiao Tan; Hong Liang; Morgan A Rousseau; Kelly M Tomasevich; Andrew G Sikora; Ilya Levental; Dharini van der Hoeven; Yong Zhou; John F Hancock; Kartik Venkatachalam
Journal:  EMBO Rep       Date:  2019-02-20       Impact factor: 8.807

8.  ORP2 interacts with phosphoinositides and controls the subcellular distribution of cholesterol.

Authors:  Annika Koponen; Amita Arora; Kohta Takahashi; Henriikka Kentala; Annukka M Kivelä; Eeva Jääskeläinen; Johan Peränen; Pentti Somerharju; Elina Ikonen; Tapani Viitala; Vesa M Olkkonen
Journal:  Biochimie       Date:  2018-12-24       Impact factor: 4.079

9.  Lysosomal calcium signalling regulates autophagy through calcineurin and ​TFEB.

Authors:  Diego L Medina; Simone Di Paola; Ivana Peluso; Andrea Armani; Diego De Stefani; Rossella Venditti; Sandro Montefusco; Anna Scotto-Rosato; Carolina Prezioso; Alison Forrester; Carmine Settembre; Wuyang Wang; Qiong Gao; Haoxing Xu; Marco Sandri; Rosario Rizzuto; Maria Antonietta De Matteis; Andrea Ballabio
Journal:  Nat Cell Biol       Date:  2015-03       Impact factor: 28.824

10.  Screening and identification of small molecule inhibitors of ErbB2-induced invasion.

Authors:  D M Brix; B Rafn; K Bundgaard Clemmensen; S H Andersen; N Ambartsumian; M Jäättelä; T Kallunki
Journal:  Mol Oncol       Date:  2014-07-12       Impact factor: 6.603

  10 in total
  1 in total

1.  Lysosomal inhibition sensitizes TMEM16A-expressing cancer cells to chemotherapy.

Authors:  Avani Vyas; Roberto Gomez-Casal; Silvia Cruz-Rangel; Hugo Villanueva; Andrew G Sikora; Pavithra Rajagopalan; Devraj Basu; Jonathan Pacheco; Gerald R V Hammond; Kirill Kiselyov; Umamaheswar Duvvuri
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-14       Impact factor: 12.779

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.